Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant loss of -66.45% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 6.17%. Over the past 30 days, the price of CNTX has leaped by -1.99%. And in the last five days, it has surged by 28.81%.
The stock of Context Therapeutics Inc (CNTX) is currently priced at $0.87. In the last session, the stock climbed significantly, topping out at $9.0 after opening at $0.87. The day’s lowest price was $4.0 before the stock closed at $0.79.
Context Therapeutics Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $2.70 on 08/19/24 and the lowest value was $0.49 on 05/30/25.
52-week price history of CNTX Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Context Therapeutics Inc’s current trading price is -67.69% away from its 52-week high, while its distance from the 52-week low is 78.02%. The stock’s price range during this period has varied between$0.49 and $2.70. The Context Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.56 million for the day, a figure considerably higher than their average daily volume of 0.24 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Context Therapeutics Inc (CNTX) has experienced a quarterly rise of 22.55% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 78.24M and boasts a workforce of 12 employees.
Context Therapeutics Inc: Analysts’ Ratings Unveiled
As of right now, 2 analysts are rating Context Therapeutics Inc as a BUY, 4 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.7272, with a change in price of +0.0073. Similarly, Context Therapeutics Inc recorded 221,459 in trading volume during the last 100 days, posting a change of +0.84%.
CNTX Stock Stochastic Average
As of today, Context Therapeutics Inc’s raw stochastic average for the last 50 days stands at 71.62%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 74.43%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 45.07% and 25.73%, respectively.
